TP53 and neoplasm: It has been reported by various studies that mutant p53 may not only lose the tumour-suppressor functions of wild-type p53, or have dominant-negative effect over endogenous wild-type p53, but also acquire additional pro-oncogenic gain-of-function activities (Sigal and Rotter, 2000; Zalcenstein et al, 2003).